ClinicalTrials.gg
RecruitingNCT04099940Updated Sep 28, 2023

Virtual Reality Avatar Therapy for People Hearing Voices

An interventional study of Virtual Reality Avatar Therapy (VRAT) and Assertiveness Training Program (ATP) in Psychosis, Schizophrenia and Schizo Affective Disorder, sponsored by Psychiatric University Hospital, Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-09-28.

Sponsored by Psychiatric University Hospital, Zurich · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Jul 2021; still recruiting 5 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Psychotic Disorders with a site in Switzerland — 10 open to participants now, 11 under way, 3 of them phase 3. Psychotic Disorders · Switzerland.

Planned enrollment
10th of 20
100 · median 100
Started
2021
with 3 others
No phase
13 of 25
6 open now
Primary completion
2025-05
later than 1 of 10 live
Registered
10th of 25
by date
Lead sponsor
3 of 25
Psychiatric University Hospital, Zurich

Among the 25 studies in Psychotic Disorders with a site in Switzerland, this one is the 10th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2021, is one of 13 with no phase, reaches primary completion later than 1 of the 10 other live ones, and was the 10th registered.

Psychotic Disorders

1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.

Browse Psychotic Disorders studies →

Open to participants now

10 of the 25 studies in Psychotic Disorders with a site in Switzerland are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Psychotic Disorders with a site in Switzerland, or all of them as a file.
02

Study summary

Hearing voices is probably the worst form of acoustic hallucinations; which can be experienced as severely disturbing and is influenced by diverse factors including the ability of the individual to influence and control the hallucinatory experience itself. In recent years virtual reality has become a treatment option. In the so-called AVATAR Therapy, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent. Avatar Therapy involves similar processes to learning and cognitive restructuring, comparable to other psychotherapeutic interventions. The investigators plan to conduct an interventional study using a cross-over design, to compare the feasibility and efficacy of virtual reality avatar therapy for patients with acoustic hallucinations (independent of psychiatric diagnosis) with a cognitive behavioural group therapy aimed to improve social competence.

03

Conditions studied

  • Psychosis
  • Schizophrenia
  • Schizo Affective Disorder
  • Hearing Voices When No One is Talking (Symptom)

Keywords

  • Hearing Voices, Virtual Reality Avatar Therapy, Cognitive Behavioural Therapy
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Consistent acoustic hallucinations, with the presence of voices for at least two months.
  • Participants are competent to give , as determined by the referring physician or psychiatrist.
  • German language proficiency as a native speaker or level B1 Common European Framework of Reference for Languages (CEFRL)

Exclusion criteria

Exclusion Criteria:

  • Current neurological disorder.
  • Current substance use or withdrawal.
  • Concomitant group psychotherapeutic intervention.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Virtual Reality Avatar Therapy (VRAT)

    In the VRAT, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent.

    Behavioral: Virtual Reality Avatar Therapy (VRAT) · Behavioral: Assertiveness Training Program (ATP)

  • Active comparator
    Assertiveness Training Program (ATP)

    The ATP is a transdiagnostic cognitive behavioural treatment programme, which aims to increase self-confidence and social competence in patients with a psychiatric disorder.

    Behavioral: Virtual Reality Avatar Therapy (VRAT) · Behavioral: Assertiveness Training Program (ATP)

Interventions

  • BehavioralVirtual Reality Avatar Therapy (VRAT)

    The Virtual Reality Avatar Therapy (VRAT) is a Cognitive Behavioral Intervention, delivered through Virtual Reality.

  • BehavioralAssertiveness Training Program (ATP)

    The Assertiveness Training Program (ATP) is a Cognitive Behavioral Intervention, delivered as group therapy.

06

What researchers measure

Primary outcomes

  1. Psychopathological Assessment

    Symptom Questionnaire

    Time frame: Change: Baseline, 3, 6 weeks, 6 and 12 months]

Secondary outcomes

  1. Psychotic Symptoms

    Symptom Questionnaire

    Time frame: Change: Baseline, 3, 6 weeks, 6 and 12 months]

  2. Insecurity- Self-confidence

    Symptom Questionnaire

    Time frame: Change: Baseline, 3, 6 weeks, 6 and 12 months]

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Craig TK, Rus-Calafell M, Ward T, Leff JP, Huckvale M, Howarth E, Emsley R, Garety PA. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry. 2018 Jan;5(1):31-40. doi: 10.1016/S2215-0366(17)30427-3. Epub 2017 Nov 23. Erratum In: Lancet Psychiatry. 2018 Jan;5(1):e1. doi: 10.1016/S2215-0366(17)30473-X. PubMed 29175276 ↗
  • Brander M, Egger ST, Hurlimann N, Seifritz E, Sumner RW, Vetter S, Magnenat S. Virtual Reality Human-Human Interface to Deliver Psychotherapy to People Experiencing Auditory Verbal Hallucinations: Development and Usability Study. JMIR Serious Games. 2021 Jun 1;9(2):e26820. doi: 10.2196/26820. PubMed 33769295 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2021 (actual). Primary completion is estimated for May 2025, 46 months after the start.

Of 460 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 46 months is above that.

Counting every sponsor, half of 462 studies reached it within 34 months; a quarter within 19 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2019
First posted
Sep 23, 2019
StartActual
Jul 1, 2021
Primary completionEst.
May 30, 2025
CompletionEst.
Dec 31, 2025
Last update
Sep 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04099940
Lead sponsor
Psychiatric University Hospital, Zurich
Responsible party
Stephan T. Egger (Senior Psychiatrists, Psychiatric University Hospital, Zurich) — Principal investigator
First posted
Sep 23, 2019
Start date
Jul 1, 2021
Primary completion
May 30, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Sep 28, 2023

Study contacts

Stephan T. Egger, MD
Contact
stephan.egger@puk.zh.ch
+41523049340

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion